Searchable abstracts of presentations at key conferences in endocrinology

ea0031p287 | Pituitary | SFEBES2013

Finally we know! ‘It comes from your pituitary'

Rashid Nazia , Baldeweg Stephanie E

Introduction: Cushing’s syndrome is broadly categorized into ACTH dependent (pituitary and ectopic source) and ACTH independent (adrenal source). Localizing source of Cushing’s can sometimes be a cumbersome diagnostic process.Case history: A 25-year-old male patient presented with sudden rapid onset weight gain, muscle weakness and occasional headaches.as well as severe dyspnoea, orthopnea and PND. There was no significant past medical or famil...

ea0021p279 | Pituitary | SFEBES2009

Echocardiography in patients with hyperprolactinaemia treated with dopamine agonists: what happens in daily clinical practice and what are the findings?

Soo Audrey , Baldeweg Stephanie E

Background: Ergot-derived dopamine agonist therapy (EDDAT) is associated with cardiac valvulopathy in Parkinson’s disease. The risk to patients with prolactinomas is uncertain. The EMEA/MRHA and BSE recently issued guidelines for surveillance echocardiography (ECHO) of patients receiving treatment with EDDAT. Our policy is to arrange opportunistic ECHO screening at first clinic visit guidelines.Objective: We investigated the uptake and findings of e...

ea0049ep1075 | Pituitary - Clinical | ECE2017

The E in POEMS syndrome: what to expect?

Caimari Francisca , D'Sa Shirley , Lunn Michael , Baldeweg Stephanie E

Introduction: POEMS syndrome is a rare multisystemic disorder including polyneuropathy, organomegaly, endocrinopathy, monoclonal plasma-proliferative disorder and skin changes. We aim to describe the course of the endocrine disease in the context of this paraneoplastic syndrome.Methods: 69 patients with POEMS have been under the MDT care in our hospital. Data is currently available for 32 patients who attended the joint haematological/neurological/endocr...

ea0050p246 | Neoplasia, Cancer and Late Effects | SFEBES2017

The course of the endocrine disease in POEMS syndrome

Caimari Francisca , D'Sa Shirley , Lunn Michael , Keddie Stephen , Baldeweg Stephanie E

Introduction: POEMS syndrome is a rare multisystem disorder characterised by polyneuropathy, organomegaly, endocrinopathy, monoclonal plasma-proliferative disorder and skin changes among other features. We describe the course of the endocrine disease in the context of this paraneoplastic syndrome.Methods: Of the 60 patients with POEMS care in hospital, data are available for 43 patients who attended the Joint POEM...

ea0050p246 | Neoplasia, Cancer and Late Effects | SFEBES2017

The course of the endocrine disease in POEMS syndrome

Caimari Francisca , D'Sa Shirley , Lunn Michael , Keddie Stephen , Baldeweg Stephanie E

Introduction: POEMS syndrome is a rare multisystem disorder characterised by polyneuropathy, organomegaly, endocrinopathy, monoclonal plasma-proliferative disorder and skin changes among other features. We describe the course of the endocrine disease in the context of this paraneoplastic syndrome.Methods: Of the 60 patients with POEMS care in hospital, data are available for 43 patients who attended the Joint POEM...

ea0038p163 | Neoplasia, cancer and late effects | SFEBES2015

Metastatic paraganglioma with isolated 3-methoxytyramine rise in a patient with SDHC mutation

Alkrekshi Akram , Abhayaratna Sachit , Pitkin Sarah , Dawnay Anne , Baldeweg Stephanie E

59-year-old gentleman with known succinate dehydrogenase complex subunit C (SDHC) gene mutation attended endocrine clinic with non-specific symptoms. Past medical history included glomus jugulare paraganglioma (PGL) surgically treated (1993, 2003) with residual disease, macroprolactinoma treated with cabergoline since 2010, and BPH treated with finasteride and tamsulosin. His brother has glomus vagale. Clinical examination was unremarkable. Plasma metanephrine ranged between 3...

ea0038p165 | Neoplasia, cancer and late effects | SFEBES2015

Lutetium ablation therapy as treatment for recurrent metastatic bladder paraganglioma

Abhayaratna Sachith , Ojewuyi Taofeek , Gaze Mark , Kar P , Baldeweg Stephanie E

We present the case of a 53 year old gentleman with recurrent bladder paraganglioma. He presented initially in 2010 with headache and blurred vision when passing urine. The tumour was surgically removed, BP normalized and his postoperative MIBG-scan was normal. The patient presented with hypertensive crisis 4 years later with a suspicion of tumor recurrence, confirmed biochemically and radiologically. Treatment with phenoxybenzamine and bisoprolol resulted in adequate BP contr...

ea0048o2 | Oral Communications | SFEEU2017

Metastatic pituitary carcinoma in an SDHB mutation positive patient

Tufton Nicola , Roncaroli Federico , Hadjudemetriou Irene , Dang Mary N , Denes Judit , Guasti Leonardo , Thom Maria , Powell Michael , Baldeweg Stephanie E , Fersht Naomi , Korbonits Marta

Case history: A 63-year-old female presented with bi-temporal hemianopia. Pituitary MRI demonstrated a macroadenoma with suprasellar extension. Her medical history included a glomus tumour of the right ear treated with external beam radiotherapy (EBRT) 25 years previously. She had no evidence of pituitary hormone abnormality and had normal urinary metanephrines levels. She underwent transsphenoidal surgery with total resection and full recovery of her visual fields. Immunohist...

ea0063oc3.2 | Cushing's and acromegaly | ECE2019

Outcomes after primary treatment for Nelson’s syndrome: a study from 13 UK centres

Fountas Athanasios , Lim Eugenie , Drake William M , Polson Andrew , Gurnell Mark , Martin Niamh M , Seejore Khyatisha , Murray Robert D , MacFarlane James , Ahluwalia Rupa , Swords Francesca , Ashraf Muhammad , Pal Aparna , Chong Zhuomin , Freel Marie , Balafshan Tala , Purewal Tejpal S , Speak Rowena G , Newell-Price John , Higham Claire , Hussein Ziad , Baldeweg Stephanie E , Dales Jolyon , Reddy Narendra , Levy Miles , Karavitaki Niki

Nelson’s syndrome (NS) is a potentially severe complication following bilateral adrenalectomy for Cushing’s disease (CD). Series assessing outcomes of treatments for NS are limited by small sample size, often short follow-up and variability of success criteria. We performed a UK multi-centre study aiming to review outcomes of primary treatment for NS. Clinical, laboratory, imaging data were collected. Kaplan-Meier method, log-rank test, Cox regression analysis were u...

ea0086p92 | Neuroendocrinology and Pituitary | SFEBES2022

Natural history of non-functioning pituitary microadenomas – results from the UK NFA consortium

Hamblin Ross , Fountas Athanasios , Lithgow Kirstie , Loughrey Paul Benjamin , Bonanos Efstathios , Khalid Shinwari Shah , Mitchell Kirsten , Shah Syed , Grixti Lydia , Matheou Mike , Isand Kristina , McLaren David , Surya Ashutosh , Zubair Ullah Hafiz , Klaucane Katarina , Jayasuriya Anuradha , Bhatti Sumbal , Mavilakandy Akash , Ahsan Masato , Mathew Susan , Hussein Ziad , Jansz Thijs , Wunna Wunna , Ayuk John , Abraham Prakash , Drake William , Brooke Antonia , Baldeweg Stephanie E. , Sam Amir H. , Martin Niamh , Higham Claire , Reddy Narendra , Ahluwalia Rupa , Newell-Price John , Vamvakopoulos Joannis , Krishnan Amutha , Lansdown Andrew , Murray Robert D , Pal Aparna , Bradley Karin , Mamoojee Yaasir , Purewal Tejpal , Panicker Janki , Marie Freel E , Hasan Faisal , Kumar Mohit , Jose Biju , Hunter Steven , Karavitaki Niki

Background: The published data on the natural history of (presumed) non-functioning pituitary microadenomas (micro-NFAs) is possibly compromised by small sample sizes, short follow-up and inclusion of cases with other pathologies in the analyses.Objective: To clarify the long-term outcomes of micro-NFAs in a large cohort of patients.Methods: We conducted a multi-centre, retrospective, cohort study involving 22 UK endocrine departme...